China-UK Antimicrobial Resistance in the Real World partnership hubs 2018 - Announcement of awards
7 February 2019
An investment of £8 million by the UK Research & Innovation (UKRI) Antimicrobial Resistance in the Real World (AMR) cross-council initiative through the Newton Fund, and 36 million yuan from the National Natural Science Foundation of China (NSFC), will support new interdisciplinary China-UK AMR partnership hubs.
According to the Jim O'Neill Review on Antimicrobial Resistance, China uses around half the antibiotics consumed worldwide. Of these, 48% are consumed by humans and the rest is used in food-producing animals. The report suggests that AMR could cause a million premature deaths per year by 2050 in China alone.
To address this problem, the UKRI AMR cross-council initiative and the NSFC have been working closely together and are funding four collaborations.
This interdisciplinary approach will enable researchers to:
- investigate in detail the emergence and spread of resistant bacteria
- understand the impact this has on the environment, agricultural systems, animals and humans using a 'one health' approach
- develop new interventions, including new drugs
- support policymakers to improve health and agricultural systems.
The new collaborations will build on the success of the 2016 China-UK AMR Partnership Initiative - external link whose research provided supporting evidence for the Chinese government's internationally recognised ban of colistin, an antibiotic of last resort, from animal use.
The four grants have been allocated to the following UK principal investigators who will each work closely with a Chinese counterpart.
|UK grant holder||UK research organisation||Chinese grant holder||Chinese research organisation||Proposal title|
|Professor Christopher Dowson||University of Warwick||Professor Jian Min Yue||Chinese Academy of Sciences||CHNUK: Integrated platforms from science to policy in response to antibacterial resistance|
|Professor Helen Lambert||University of Bristol||Professor Bo Zheng||Peking University Health Science Centre||Strategies to reduce the burden of antibiotic resistance in China|
|Dr Alan McNally||University of Birmingham||Professor Yunsong Yu||Zhejiang University||DETECTIVE: Dissemination & resistance mechanisms of carbapenem-resistant gram-negative bacilli|
|Professor Timothy Walsh||Cardiff University||Dr Yang Wang||China Agricultural University||Determining the clinical and environmental impact, burden & cost of extensively drug resistant enterobacteriaceae in China (DETER-XDRE-CHINA-HUB)|
Further details can be found on the MRC website - external link .
For further information, please contact: